Trial Profile
Eltrombopag and high-dose dexamethasone as first line treatment for immune thrombocytopenia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 May 2014
Price :
$35
*
At a glance
- Drugs Eltrombopag (Primary) ; Dexamethasone
- Indications Idiopathic thrombocytopenic purpura
- Focus Therapeutic Use
- 09 May 2014 New trial record